Korro Bio, Inc.
KRRO • NASDAQ
Korro Bio, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ram Aiyar, with a market cap of $188.6M.
Market Cap$188.6M
Employees101.0
CEORam Aiyar
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 3 weeksQ1 2026
Financials
Korro Bio, Inc. FAQ
Common questions about Korro Bio, Inc.
Korro Bio, Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026. Analysts estimate revenue of $862.9K.
Korro Bio, Inc. has approximately 101 employees.